Login / Signup

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification.

Jakub TrizuljakWolfgang R SperrLucie NekvindováJoanne N G Oude ElberinkKaroline V GleixnerAleksandra GorskaMagdalena LangeKarin HartmannAnja IllerhausMassimiliano BonifacioCecelia PerkinsChiara ElenaLuca MalcovatiAnna Belloni FortinaKhalid ShoumariyehMohamad JawharRoberta ZanottiPatrizia BonadonnaFrancesca CaroppoAlexander ZinkMassimo TriggianiRoberta ParenteNikolas von BubnoffAkif Selim YavuzHans HägglundMattias MattssonJens Peter PanseNadja JäkelAlex KilbertusOlivier HermineMichel ArockDavid FuchsVito SabatoKnut BrockowAgnes BretterklieberMarek NiedoszytkoBjörn van AnrooijAndreas ReiterJason GotlibHanneke C Kluin-NelemansJiří MayerMichael DoubekPeter Valent
Published in: Allergy (2020)
Our data confirm the clinical impact of the WHO classification that separates ISM from CM and from other SM variants.
Keyphrases
  • deep learning
  • machine learning
  • big data
  • copy number
  • electronic health record
  • artificial intelligence
  • gene expression
  • drug induced